APO Research
Talk to an analyst

APO RESEARCH · REPORT

Beauty Peptide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Beauty Peptide Market Outlook and Growth Opportunities 2026

10 April 2026Not stated

Choose your research edition.

Industry ResearchBeauty Peptide Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Beauty Peptide Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Beauty Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Beauty Peptide Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Beauty Peptide Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Beauty Peptide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Beauty Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Beauty Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Beauty Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Beauty Peptide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Beauty Peptide market include Readline Biotech, Pentapharm, Pentapharm, Lipotec, ISP, Helix BioMedix, Evonil and Atrium, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Beauty Peptide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Beauty Peptide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Beauty Peptide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Beauty Peptide market size, projected growth trends, production technologies, key applications, and end-use industries.

Beauty Peptide Segment by Company

Readline Biotech

Pentapharm

Pentapharm

Lipotec

ISP

Helix BioMedix

Evonil

Atrium

Beauty Peptide Segment by Type

Signal Peptides

Neurotransmitter-Inhibiting Peptides

Carried Peptides

Beauty Peptide Segment by Application

Anti-ageing

Whitening

Others

Beauty Peptide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Beauty Peptide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Beauty Peptide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Beauty Peptide significant trends, drivers, influence factors in global and regions.

6. To analyze Beauty Peptide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beauty Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Beauty Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beauty Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Beauty Peptide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Beauty Peptide industry.

Chapter 3: Detailed analysis of Beauty Peptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Beauty Peptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Beauty Peptide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Beauty Peptide Industry Trends Table 2. Beauty Peptide Industry Drivers Table 3. Beauty Peptide Industry Opportunities and Challenges Table 4. Beauty Peptide Industry Restraints Table 5. Global Beauty Peptide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Beauty Peptide Revenue Share by Company (2021-2026) Table 7. Global Beauty Peptide Sales Volume by Company (t) & (2021-2026) Table 8. Global Beauty Peptide Sales Volume Share by Company (2021-2026) Table 9. Global Beauty Peptide Average Price (USD/t) of Company (2021-2026) Table 10. Global Beauty Peptide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Beauty Peptide Key Company Manufacturing Base & Headquarters Table 12. Global Beauty Peptide Company, Product Type & Application Table 13. Global Beauty Peptide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Beauty Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Signal Peptides Table 18. Significant Companies of Neurotransmitter-Inhibiting Peptides Table 19. Significant Companies of Carried Peptides Table 20. Global Beauty Peptide Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Beauty Peptide Sales Volume by Type (2021-2026) & (t) Table 22. Global Beauty Peptide Sales Volume by Type (2027-2032) & (t) Table 23. Global Beauty Peptide Sales Volume Share by Type (2021-2026) Table 24. Global Beauty Peptide Sales Volume Share by Type (2027-2032) Table 25. Global Beauty Peptide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Beauty Peptide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Beauty Peptide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Beauty Peptide Sales Value Share by Type (2021-2026) Table 29. Global Beauty Peptide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Anti-ageing Table 31. Significant Companies of Whitening Table 32. Significant Companies of Others Table 33. Global Beauty Peptide Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Beauty Peptide Sales Volume by Application (2021-2026) & (t) Table 35. Global Beauty Peptide Sales Volume by Application (2027-2032) & (t) Table 36. Global Beauty Peptide Sales Volume Share by Application (2021-2026) Table 37. Global Beauty Peptide Sales Volume Share by Application (2027-2032) Table 38. Global Beauty Peptide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Beauty Peptide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Beauty Peptide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Beauty Peptide Sales Value Share by Application (2021-2026) Table 42. Global Beauty Peptide Sales Value Share by Application (2027-2032) Table 43. Global Beauty Peptide Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Beauty Peptide Sales by Region (2021-2026) & (t) Table 45. Global Beauty Peptide Sales Market Share by Region (2021-2026) Table 46. Global Beauty Peptide Sales by Region (2027-2032) & (t) Table 47. Global Beauty Peptide Sales Market Share by Region (2027-2032) Table 48. Global Beauty Peptide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Beauty Peptide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Beauty Peptide Sales Value Share by Region (2021-2026) Table 51. Global Beauty Peptide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Beauty Peptide Sales Value Share by Region (2027-2032) Table 53. Global Beauty Peptide Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Beauty Peptide Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Beauty Peptide Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Beauty Peptide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Beauty Peptide Sales by Country (2021-2026) & (t) Table 58. Global Beauty Peptide Sales Market Share by Country (2021-2026) Table 59. Global Beauty Peptide Sales by Country (2027-2032) & (t) Table 60. Global Beauty Peptide Sales Market Share by Country (2027-2032) Table 61. Global Beauty Peptide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Beauty Peptide Sales Value Market Share by Country (2021-2026) Table 63. Global Beauty Peptide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Beauty Peptide Sales Value Market Share by Country (2027-2032) Table 65. Readline Biotech Company Information Table 66. Readline Biotech Business Overview Table 67. Readline Biotech Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. Readline Biotech Beauty Peptide Product Portfolio Table 69. Readline Biotech Recent Development Table 70. Pentapharm Company Information Table 71. Pentapharm Business Overview Table 72. Pentapharm Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Pentapharm Beauty Peptide Product Portfolio Table 74. Pentapharm Recent Development Table 75. Pentapharm Company Information Table 76. Pentapharm Business Overview Table 77. Pentapharm Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Pentapharm Beauty Peptide Product Portfolio Table 79. Pentapharm Recent Development Table 80. Lipotec Company Information Table 81. Lipotec Business Overview Table 82. Lipotec Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Lipotec Beauty Peptide Product Portfolio Table 84. Lipotec Recent Development Table 85. ISP Company Information Table 86. ISP Business Overview Table 87. ISP Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. ISP Beauty Peptide Product Portfolio Table 89. ISP Recent Development Table 90. Helix BioMedix Company Information Table 91. Helix BioMedix Business Overview Table 92. Helix BioMedix Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Helix BioMedix Beauty Peptide Product Portfolio Table 94. Helix BioMedix Recent Development Table 95. Evonil Company Information Table 96. Evonil Business Overview Table 97. Evonil Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Evonil Beauty Peptide Product Portfolio Table 99. Evonil Recent Development Table 100. Atrium Company Information Table 101. Atrium Business Overview Table 102. Atrium Beauty Peptide Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Atrium Beauty Peptide Product Portfolio Table 104. Atrium Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Beauty Peptide Distributors List Table 108. Beauty Peptide Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Beauty Peptide Product Image Figure 2. Global Beauty Peptide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Beauty Peptide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Beauty Peptide Sales (2021-2032) & (t) Figure 5. Global Beauty Peptide Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Beauty Peptide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Signal Peptides Image Figure 10. Neurotransmitter-Inhibiting Peptides Image Figure 11. Carried Peptides Image Figure 12. Global Beauty Peptide Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Beauty Peptide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Beauty Peptide Sales Volume Share by Type (2021-2032) Figure 15. Global Beauty Peptide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Beauty Peptide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Beauty Peptide Sales Value Share by Type (2021-2032) Figure 18. Anti-ageing Image Figure 19. Whitening Image Figure 20. Others Image Figure 21. Global Beauty Peptide Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Beauty Peptide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Beauty Peptide Sales Volume Share by Application (2021-2032) Figure 24. Global Beauty Peptide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Beauty Peptide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Beauty Peptide Sales Value Share by Application (2021-2032) Figure 27. Global Beauty Peptide Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Beauty Peptide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Beauty Peptide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Beauty Peptide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Beauty Peptide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Beauty Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Beauty Peptide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Beauty Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Beauty Peptide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Beauty Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Beauty Peptide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Beauty Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Beauty Peptide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Beauty Peptide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Beauty Peptide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Beauty Peptide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Beauty Peptide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Beauty Peptide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Beauty Peptide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Signal Peptides
  • Neurotransmitter-Inhibiting Peptides
  • Carried Peptides
Applications
  • Anti-ageing
  • Whitening
  • Others
Companies covered
  • Readline Biotech
  • Pentapharm
  • Pentapharm
  • Lipotec
  • ISP
  • Helix BioMedix
  • Evonil
  • Atrium

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Beauty Peptide Sales Value (2021-2032)
  4. 1.2.2 Global Beauty Peptide Sales Volume (2021-2032)
  5. 1.2.3 Global Beauty Peptide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Beauty Peptide Market Dynamics
  1. 2.1 Beauty Peptide Industry Trends
  2. 2.2 Beauty Peptide Industry Drivers
  3. 2.3 Beauty Peptide Industry Opportunities and Challenges
  4. 2.4 Beauty Peptide Industry Restraints
3 Beauty Peptide Market by Company
  1. 3.1 Global Beauty Peptide Company Revenue Ranking in 2025
  2. 3.2 Global Beauty Peptide Revenue by Company (2021-2026)
  3. 3.3 Global Beauty Peptide Sales Volume by Company (2021-2026)
  4. 3.4 Global Beauty Peptide Average Price by Company (2021-2026)
  5. 3.5 Global Beauty Peptide Company Ranking (2024-2026)
  6. 3.6 Global Beauty Peptide Company Manufacturing Base and Headquarters
  7. 3.7 Global Beauty Peptide Company Product Type and Application
  8. 3.8 Global Beauty Peptide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Beauty Peptide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Beauty Peptide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Beauty Peptide Market by Type
  1. 4.1 Beauty Peptide Type Introduction
  2. 4.1.1 Signal Peptides
  3. 4.1.2 Neurotransmitter-Inhibiting Peptides
  4. 4.1.3 Carried Peptides
  5. 4.2 Global Beauty Peptide Sales Volume by Type
  6. 4.2.1 Global Beauty Peptide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Beauty Peptide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Beauty Peptide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Beauty Peptide Sales Value by Type
  10. 4.3.1 Global Beauty Peptide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Beauty Peptide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Beauty Peptide Sales Value Share by Type (2021-2032)
5 Beauty Peptide Market by Application
  1. 5.1 Beauty Peptide Application Introduction
  2. 5.1.1 Anti-ageing
  3. 5.1.2 Whitening
  4. 5.1.3 Others
  5. 5.2 Global Beauty Peptide Sales Volume by Application
  6. 5.2.1 Global Beauty Peptide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Beauty Peptide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Beauty Peptide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Beauty Peptide Sales Value by Application
  10. 5.3.1 Global Beauty Peptide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Beauty Peptide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Beauty Peptide Sales Value Share by Application (2021-2032)
6 Beauty Peptide Regional Sales and Value Analysis
  1. 6.1 Global Beauty Peptide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Beauty Peptide Sales by Region (2021-2032)
  3. 6.2.1 Global Beauty Peptide Sales by Region: 2021-2026
  4. 6.2.2 Global Beauty Peptide Sales by Region (2027-2032)
  5. 6.3 Global Beauty Peptide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Beauty Peptide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Beauty Peptide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Beauty Peptide Sales Value by Region (2027-2032)
  9. 6.5 Global Beauty Peptide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Beauty Peptide Sales Value (2021-2032)
  12. 6.6.2 North America Beauty Peptide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Beauty Peptide Sales Value (2021-2032)
  15. 6.7.2 Europe Beauty Peptide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Beauty Peptide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Beauty Peptide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Beauty Peptide Sales Value (2021-2032)
  21. 6.9.2 South America Beauty Peptide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Beauty Peptide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Beauty Peptide Sales Value Share by Country, 2025 VS 2032
7 Beauty Peptide Country-level Sales and Value Analysis
  1. 7.1 Global Beauty Peptide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Beauty Peptide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Beauty Peptide Sales by Country (2021-2032)
  4. 7.3.1 Global Beauty Peptide Sales by Country (2021-2026)
  5. 7.3.2 Global Beauty Peptide Sales by Country (2027-2032)
  6. 7.4 Global Beauty Peptide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Beauty Peptide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Beauty Peptide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Beauty Peptide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Beauty Peptide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Beauty Peptide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Beauty Peptide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Beauty Peptide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Beauty Peptide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Beauty Peptide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Beauty Peptide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Beauty Peptide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Beauty Peptide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Beauty Peptide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Beauty Peptide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Beauty Peptide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Beauty Peptide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Beauty Peptide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Beauty Peptide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Beauty Peptide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Beauty Peptide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Beauty Peptide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Beauty Peptide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Beauty Peptide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Beauty Peptide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Beauty Peptide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Beauty Peptide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Beauty Peptide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Beauty Peptide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Beauty Peptide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Beauty Peptide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Beauty Peptide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Beauty Peptide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Beauty Peptide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Readline Biotech
  2. 8.1.1 Readline Biotech Company Information
  3. 8.1.2 Readline Biotech Business Overview
  4. 8.1.3 Readline Biotech Beauty Peptide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Readline Biotech Beauty Peptide Product Portfolio
  6. 8.1.5 Readline Biotech Recent Developments
  7. 8.2 Pentapharm
  8. 8.2.1 Pentapharm Company Information
  9. 8.2.2 Pentapharm Business Overview
  10. 8.2.3 Pentapharm Beauty Peptide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pentapharm Beauty Peptide Product Portfolio
  12. 8.2.5 Pentapharm Recent Developments
  13. 8.3 Pentapharm
  14. 8.3.1 Pentapharm Company Information
  15. 8.3.2 Pentapharm Business Overview
  16. 8.3.3 Pentapharm Beauty Peptide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pentapharm Beauty Peptide Product Portfolio
  18. 8.3.5 Pentapharm Recent Developments
  19. 8.4 Lipotec
  20. 8.4.1 Lipotec Company Information
  21. 8.4.2 Lipotec Business Overview
  22. 8.4.3 Lipotec Beauty Peptide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lipotec Beauty Peptide Product Portfolio
  24. 8.4.5 Lipotec Recent Developments
  25. 8.5 ISP
  26. 8.5.1 ISP Company Information
  27. 8.5.2 ISP Business Overview
  28. 8.5.3 ISP Beauty Peptide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ISP Beauty Peptide Product Portfolio
  30. 8.5.5 ISP Recent Developments
  31. 8.6 Helix BioMedix
  32. 8.6.1 Helix BioMedix Company Information
  33. 8.6.2 Helix BioMedix Business Overview
  34. 8.6.3 Helix BioMedix Beauty Peptide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Helix BioMedix Beauty Peptide Product Portfolio
  36. 8.6.5 Helix BioMedix Recent Developments
  37. 8.7 Evonil
  38. 8.7.1 Evonil Company Information
  39. 8.7.2 Evonil Business Overview
  40. 8.7.3 Evonil Beauty Peptide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Evonil Beauty Peptide Product Portfolio
  42. 8.7.5 Evonil Recent Developments
  43. 8.8 Atrium
  44. 8.8.1 Atrium Company Information
  45. 8.8.2 Atrium Business Overview
  46. 8.8.3 Atrium Beauty Peptide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Atrium Beauty Peptide Product Portfolio
  48. 8.8.5 Atrium Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Beauty Peptide Value Chain Analysis
  2. 9.1.1 Beauty Peptide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Beauty Peptide Sales Mode & Process
  6. 9.2 Beauty Peptide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Beauty Peptide Distributors
  9. 9.2.3 Beauty Peptide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst